蛋白质学与剂量反应相遇:解读药物效应的新范式
Chenwei Wang1,2, Bing Zhang1,2
1Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.
Cancer research
|June 26, 2024
概括
埃克特及其同事开发了DecryptE,这是一种新的剂量解析蛋白质组学方法. 这种高通量平台量化了数千种蛋白质,推动了药物机制的发现和治疗策略的开发.
科学领域:
- 蛋白质组学是指蛋白质组学.
- 药理学 药理学是指药理学的学科.
- 生物技术是生物技术.
背景情况:
- 在蛋白质层面了解药物效应对于推动药理学研究至关重要.
- 现有的方法可能缺乏吞吐量或分辨率来捕获全面的剂量反应蛋白质组数据.
研究的目的:
- 推出DecryptE,一种用于剂量解析蛋白质组学的创新方法.
- 建立一个高通量平台来分析药物对蛋白质组的影响.
- 为药物机制发现产生一个全面的资源.
主要方法:
- 集成先进的样本制备和质谱技术.
- 开发一个能够每小时量化超过7000种蛋白质的平台.
- 申请使用Jurkat细胞研究144种药物,生成超过100万个剂量反应曲线.
主要成果:
- 证明了可靠和一致的结果的卓越可复制性.
- 能够识别对药物的反应中蛋白质表达的微妙变化.
- 基于蛋白质组概况,促进了药物的聚类,揭示了新的机制.
结论:
- DecryptE显著提高了对蛋白质层次药物效应的理解.
- 该平台为研究社区提供了宝贵的资源.
- 蛋白质组学与剂量反应分析的整合为未来的治疗策略提供了潜力.
更多相关视频
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
5.0K
00:05A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction
Published on: August 27, 2019
16.3K
相关概念视频
Dose-Response Relationship: Overview
3.1K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
3.1K
Proteomics
7.3K
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
7.3K
Dose-Response Relationship: Potency and Efficacy
4.3K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.3K
Drug Concentrations: Measurements
355
Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma...
Plasma...
355
Agonism and Antagonism: Quantification
352
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
352
Analysis of Population Pharmacokinetic Data
252
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
252
